Interpretation of Incidence Rates Data
Incidence Rate Report by State
Kidney & Renal Pelvis (Late Stage^), 2016-2020
All Races (includes Hispanic), Female, All Ages
Sorted by Percentlate
Explanation of Column HeadersObjective - The objective of *** is from the Healthy People 2020 project done by the Centers for Disease Control and Prevention.
Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.Percent of Cases with Late Stage - This is the number of late stages cases compared to the number of cases for all stages.
Other Notes
- Larger confidence intervals indicate less stability of the data. This is often due to low counts that are not quite low enough to be suppressed.
- Data is currently being suppressed if there are fewer than 16 counts for the time period.
Line by Line Interpretation of the Report
US (SEER+NPCR)1
- Rate : The incidence rate is 2.9 with a 95% confidence interval from 2.9 to 3.0 and 6,093 average annual cases over 2016-2020.
- CI*Rank⋔ : N/A
- Percent of Cases with Late Stage : 25.6
Puerto Rico6
- Rate : The incidence rate is 1.2 with a 95% confidence interval from 1.0 to 1.4 and 27 average annual cases over 2016-2020.
- CI*Rank⋔ : N/A
- Percent of Cases with Late Stage : 21.1
Mississippi6
- Rate : The incidence rate is 3.3 with a 95% confidence interval from 2.9 to 3.6 and 64 average annual cases over 2016-2020.
- CI*Rank⋔ : 17 (3, 36)
- Percent of Cases with Late Stage : 21.2
Alabama6
- Rate : The incidence rate is 2.7 with a 95% confidence interval from 2.4 to 2.9 and 89 average annual cases over 2016-2020.
- CI*Rank⋔ : 39 (21, 48)
- Percent of Cases with Late Stage : 21.4
Arkansas6
- Rate : The incidence rate is 3.4 with a 95% confidence interval from 3.1 to 3.8 and 67 average annual cases over 2016-2020.
- CI*Rank⋔ : 9 (1, 29)
- Percent of Cases with Late Stage : 21.8
Tennessee6
- Rate : The incidence rate is 3.1 with a 95% confidence interval from 2.9 to 3.3 and 141 average annual cases over 2016-2020.
- CI*Rank⋔ : 22 (9, 34)
- Percent of Cases with Late Stage : 22.7
Delaware6
- Rate : The incidence rate is 2.5 with a 95% confidence interval from 2.0 to 3.1 and 18 average annual cases over 2016-2020.
- CI*Rank⋔ : 43 (10, 49)
- Percent of Cases with Late Stage : 23.1
Virginia6
- Rate : The incidence rate is 2.4 with a 95% confidence interval from 2.2 to 2.6 and 131 average annual cases over 2016-2020.
- CI*Rank⋔ : 47 (35, 49)
- Percent of Cases with Late Stage : 23.2
Maryland6
- Rate : The incidence rate is 2.6 with a 95% confidence interval from 2.4 to 2.9 and 104 average annual cases over 2016-2020.
- CI*Rank⋔ : 41 (23, 48)
- Percent of Cases with Late Stage : 23.3
South Carolina6
- Rate : The incidence rate is 2.7 with a 95% confidence interval from 2.5 to 3.0 and 97 average annual cases over 2016-2020.
- CI*Rank⋔ : 38 (20, 48)
- Percent of Cases with Late Stage : 23.3
Alaska6
- Rate : The incidence rate is 2.9 with a 95% confidence interval from 2.2 to 3.8 and 11 average annual cases over 2016-2020.
- CI*Rank⋔ : 27 (1, 49)
- Percent of Cases with Late Stage : 24.0
Kansas6
- Rate : The incidence rate is 3.2 with a 95% confidence interval from 2.8 to 3.6 and 58 average annual cases over 2016-2020.
- CI*Rank⋔ : 20 (4, 41)
- Percent of Cases with Late Stage : 24.0
North Carolina6
- Rate : The incidence rate is 2.9 with a 95% confidence interval from 2.8 to 3.1 and 205 average annual cases over 2016-2020.
- CI*Rank⋔ : 26 (17, 40)
- Percent of Cases with Late Stage : 24.0
District of Columbia6
- Rate : The incidence rate is 2.0 with a 95% confidence interval from 1.5 to 2.8 and 8 average annual cases over 2016-2020.
- CI*Rank⋔ : 49 (21, 49)
- Percent of Cases with Late Stage : 24.1
New Hampshire6
- Rate : The incidence rate is 2.5 with a 95% confidence interval from 2.0 to 3.0 and 25 average annual cases over 2016-2020.
- CI*Rank⋔ : 46 (18, 49)
- Percent of Cases with Late Stage : 24.5
Arizona6
- Rate : The incidence rate is 2.6 with a 95% confidence interval from 2.4 to 2.8 and 120 average annual cases over 2016-2020.
- CI*Rank⋔ : 42 (26, 49)
- Percent of Cases with Late Stage : 24.6
Colorado6
- Rate : The incidence rate is 2.5 with a 95% confidence interval from 2.2 to 2.7 and 82 average annual cases over 2016-2020.
- CI*Rank⋔ : 44 (27, 49)
- Percent of Cases with Late Stage : 24.7
Texas3
- Rate : The incidence rate is 3.4 with a 95% confidence interval from 3.3 to 3.6 and 541 average annual cases over 2016-2020.
- CI*Rank⋔ : 10 (5, 19)
- Percent of Cases with Late Stage : 24.7
Florida6
- Rate : The incidence rate is 2.5 with a 95% confidence interval from 2.4 to 2.6 and 400 average annual cases over 2016-2020.
- CI*Rank⋔ : 45 (37, 49)
- Percent of Cases with Late Stage : 25.1
Louisiana3
- Rate : The incidence rate is 3.9 with a 95% confidence interval from 3.6 to 4.3 and 119 average annual cases over 2016-2020.
- CI*Rank⋔ : 1 (1, 12)
- Percent of Cases with Late Stage : 25.4
Oklahoma6
- Rate : The incidence rate is 3.9 with a 95% confidence interval from 3.5 to 4.2 and 97 average annual cases over 2016-2020.
- CI*Rank⋔ : 4 (1, 14)
- Percent of Cases with Late Stage : 25.4
Kentucky3
- Rate : The incidence rate is 3.6 with a 95% confidence interval from 3.3 to 3.9 and 108 average annual cases over 2016-2020.
- CI*Rank⋔ : 7 (1, 21)
- Percent of Cases with Late Stage : 25.5
South Dakota6
- Rate : The incidence rate is 3.3 with a 95% confidence interval from 2.6 to 4.1 and 19 average annual cases over 2016-2020.
- CI*Rank⋔ : 14 (1, 48)
- Percent of Cases with Late Stage : 25.5
Michigan6
- Rate : The incidence rate is 2.7 with a 95% confidence interval from 2.6 to 2.9 and 189 average annual cases over 2016-2020.
- CI*Rank⋔ : 36 (22, 45)
- Percent of Cases with Late Stage : 25.6
New York3
- Rate : The incidence rate is 2.8 with a 95% confidence interval from 2.6 to 2.9 and 365 average annual cases over 2016-2020.
- CI*Rank⋔ : 34 (23, 43)
- Percent of Cases with Late Stage : 25.6
Idaho3
- Rate : The incidence rate is 3.0 with a 95% confidence interval from 2.5 to 3.5 and 33 average annual cases over 2016-2020.
- CI*Rank⋔ : 24 (4, 48)
- Percent of Cases with Late Stage : 25.8
Utah3
- Rate : The incidence rate is 2.6 with a 95% confidence interval from 2.3 to 3.1 and 39 average annual cases over 2016-2020.
- CI*Rank⋔ : 40 (17, 49)
- Percent of Cases with Late Stage : 25.8
Missouri6
- Rate : The incidence rate is 3.5 with a 95% confidence interval from 3.2 to 3.8 and 146 average annual cases over 2016-2020.
- CI*Rank⋔ : 8 (3, 22)
- Percent of Cases with Late Stage : 25.9
Pennsylvania6
- Rate : The incidence rate is 2.8 with a 95% confidence interval from 2.7 to 3.0 and 263 average annual cases over 2016-2020.
- CI*Rank⋔ : 30 (20, 42)
- Percent of Cases with Late Stage : 25.9
North Dakota6
- Rate : The incidence rate is 3.0 with a 95% confidence interval from 2.3 to 3.8 and 14 average annual cases over 2016-2020.
- CI*Rank⋔ : 25 (1, 49)
- Percent of Cases with Late Stage : 26.1
Nebraska6
- Rate : The incidence rate is 3.3 with a 95% confidence interval from 2.8 to 3.8 and 39 average annual cases over 2016-2020.
- CI*Rank⋔ : 15 (2, 41)
- Percent of Cases with Late Stage : 26.2
West Virginia6
- Rate : The incidence rate is 3.9 with a 95% confidence interval from 3.4 to 4.5 and 52 average annual cases over 2016-2020.
- CI*Rank⋔ : 2 (1, 19)
- Percent of Cases with Late Stage : 26.2
Maine6
- Rate : The incidence rate is 2.9 with a 95% confidence interval from 2.4 to 3.4 and 30 average annual cases over 2016-2020.
- CI*Rank⋔ : 29 (7, 49)
- Percent of Cases with Late Stage : 26.6
Georgia3
- Rate : The incidence rate is 3.2 with a 95% confidence interval from 3.0 to 3.4 and 204 average annual cases over 2016-2020.
- CI*Rank⋔ : 19 (8, 29)
- Percent of Cases with Late Stage : 26.8
Illinois3
- Rate : The incidence rate is 3.3 with a 95% confidence interval from 3.1 to 3.4 and 270 average annual cases over 2016-2020.
- CI*Rank⋔ : 16 (7, 25)
- Percent of Cases with Late Stage : 26.8
Ohio6
- Rate : The incidence rate is 3.3 with a 95% confidence interval from 3.1 to 3.5 and 263 average annual cases over 2016-2020.
- CI*Rank⋔ : 13 (6, 25)
- Percent of Cases with Late Stage : 26.8
Connecticut3
- Rate : The incidence rate is 2.8 with a 95% confidence interval from 2.5 to 3.1 and 69 average annual cases over 2016-2020.
- CI*Rank⋔ : 35 (17, 48)
- Percent of Cases with Late Stage : 26.9
New Jersey3
- Rate : The incidence rate is 2.8 with a 95% confidence interval from 2.6 to 3.0 and 169 average annual cases over 2016-2020.
- CI*Rank⋔ : 33 (21, 45)
- Percent of Cases with Late Stage : 27.0
California3
- Rate : The incidence rate is 2.7 with a 95% confidence interval from 2.6 to 2.8 and 645 average annual cases over 2016-2020.
- CI*Rank⋔ : 37 (26, 43)
- Percent of Cases with Late Stage : 27.3
Washington5
- Rate : The incidence rate is 2.9 with a 95% confidence interval from 2.6 to 3.1 and 134 average annual cases over 2016-2020.
- CI*Rank⋔ : 28 (17, 43)
- Percent of Cases with Late Stage : 27.6
Massachusetts3
- Rate : The incidence rate is 2.8 with a 95% confidence interval from 2.6 to 3.0 and 131 average annual cases over 2016-2020.
- CI*Rank⋔ : 31 (19, 45)
- Percent of Cases with Late Stage : 27.7
Oregon6
- Rate : The incidence rate is 2.8 with a 95% confidence interval from 2.5 to 3.1 and 79 average annual cases over 2016-2020.
- CI*Rank⋔ : 32 (16, 47)
- Percent of Cases with Late Stage : 27.9
Wisconsin6
- Rate : The incidence rate is 3.4 with a 95% confidence interval from 3.1 to 3.7 and 132 average annual cases over 2016-2020.
- CI*Rank⋔ : 11 (4, 25)
- Percent of Cases with Late Stage : 28.3
Minnesota6
- Rate : The incidence rate is 3.1 with a 95% confidence interval from 2.9 to 3.4 and 112 average annual cases over 2016-2020.
- CI*Rank⋔ : 21 (8, 37)
- Percent of Cases with Late Stage : 28.6
Iowa3
- Rate : The incidence rate is 3.7 with a 95% confidence interval from 3.4 to 4.1 and 82 average annual cases over 2016-2020.
- CI*Rank⋔ : 5 (1, 19)
- Percent of Cases with Late Stage : 29.2
Vermont6
- Rate : The incidence rate is 3.4 with a 95% confidence interval from 2.6 to 4.3 and 15 average annual cases over 2016-2020.
- CI*Rank⋔ : 12 (1, 48)
- Percent of Cases with Late Stage : 29.2
Montana6
- Rate : The incidence rate is 3.2 with a 95% confidence interval from 2.6 to 3.9 and 23 average annual cases over 2016-2020.
- CI*Rank⋔ : 18 (1, 48)
- Percent of Cases with Late Stage : 29.4
Hawaii3
- Rate : The incidence rate is 2.4 with a 95% confidence interval from 2.0 to 2.9 and 23 average annual cases over 2016-2020.
- CI*Rank⋔ : 48 (19, 49)
- Percent of Cases with Late Stage : 29.6
Wyoming6
- Rate : The incidence rate is 3.1 with a 95% confidence interval from 2.3 to 4.0 and 12 average annual cases over 2016-2020.
- CI*Rank⋔ : 23 (1, 49)
- Percent of Cases with Late Stage : 29.6
New Mexico3
- Rate : The incidence rate is 3.6 with a 95% confidence interval from 3.1 to 4.1 and 49 average annual cases over 2016-2020.
- CI*Rank⋔ : 6 (1, 28)
- Percent of Cases with Late Stage : 32.1
Rhode Island6
- Rate : The incidence rate is 3.9 with a 95% confidence interval from 3.3 to 4.6 and 28 average annual cases over 2016-2020.
- CI*Rank⋔ : 3 (1, 28)
- Percent of Cases with Late Stage : 35.1
- Rate : Data not available for this combination of data selections.
- CI*Rank⋔ : N/A
- Percent of Cases with Late Stage : data not available
- Rate : Data not available for this combination of data selections.
- CI*Rank⋔ : N/A
- Percent of Cases with Late Stage : data not available
Notes:
Created by statecancerprofiles.cancer.gov on 07/05/2024 7:27 pm.
State Cancer Registries may provide more current or more local data.
Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Indiana, Nevada
† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.
Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.
^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.
Data not available for this combination of data selections.
Source: SEER and NPCR data. For more specific information please see the table.
Data not available for this combination of geography, cancer site, age, and race/ethnicity.
Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.